HopeStage
Back to all studies
CompletedNCT00952757

Changes in high prolactin levels after switching to quetiapine

About this titleRead the official source — NCT00952757
Observational studyAges 18–50SpainSchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 50 years.

Listed locations
Ávila and 5 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJune 2007
Recruitment status
Completed
Enrollment listed in the registry
35
Sponsor
Investigaciones Médicas Montejo S.L.
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Interview / survey / observational
Locations
Spain
Age range
From 18 Years to 50 Years
Official registry ID
NCT00952757
Official title
Show the full official title

Changes in Hyperprolactinemia Secondary to Antipsychotics After Switching to Quetiapine: a Naturalistic, Prospective, Multicentric Observational Study of 6 Months Follow-up

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Ávila · Burgos · Palencia

3 more locations
  • Salamanca
  • Valladolid
  • Zamora

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Investigaciones Médicas Montejo S.L.

Who was this study for?

Listed age limits: 18 years to 50 years.

Want to explore more studies?

Explore studies